Nerinetide
- Generic Name
- Nerinetide
- Drug Type
- Biotech
- CAS Number
- 500992-11-0
- Unique Ingredient Identifier
- D45TI2TWMA
- Background
Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).
Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- NoNO Inc.
- Target Recruit Count
- 850
- Registration Number
- NCT04462536
- Locations
- π¨π¦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
π¨π¦St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada
π¨π¦Toronto Western Hospital, Toronto, Ontario, Canada
Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke
- First Posted Date
- 2016-10-11
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- NoNO Inc.
- Target Recruit Count
- 1105
- Registration Number
- NCT02930018
- Locations
- πΊπΈ
Riverside Radiology, Columbus, Ohio, United States
π¨π¦Sunnybrook Health Centre, Toronto, Ontario, Canada
π¨π¦University Health Network - Toronto Western Hospital, Toronto, Ontario, Canada
Field Randomization of Nerinetide (NA-1) Therapy in Early Responders
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- NoNO Inc.
- Target Recruit Count
- 532
- Registration Number
- NCT02315443
- Locations
- π¨π¦
Royal Columbian Hospital, New Westminster, British Columbia, Canada
π¨π¦Kelowna General Hospital, Kelowna, British Columbia, Canada
π¨π¦Vancouver General Hospital, Vancouver Coastal Health, Vancouver, British Columbia, Canada
Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms
- Conditions
- Subarachnoid HemorrhageRuptured Intracranial Aneurysm
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-02-06
- Last Posted Date
- 2015-08-04
- Lead Sponsor
- NoNO Inc.
- Registration Number
- NCT02056574
- Locations
- π¨π¦
Foothills Medical Centre, Calgary, Alberta, Canada
π¨π¦QEII Health Sciences Centre - Halifax Infirmary, Halifax, Nova Scotia, Canada
πΊπΈBarrow Neurological Institute, Phoenix, Arizona, United States
Evaluating Neuroprotection in Aneurysm Coiling Therapy
- First Posted Date
- 2008-08-05
- Last Posted Date
- 2013-10-17
- Lead Sponsor
- NoNO Inc.
- Target Recruit Count
- 185
- Registration Number
- NCT00728182
- Locations
- πΊπΈ
Barrow Neurological Institute, Phoenix, Arizona, United States
π¨π¦University of Alberta Hospital, Edmonton, Alberta, Canada
π¨π¦QEII Health Sciences Centre - Halifax Infirmary, Halifax, Nova Scotia, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.